Cargando…
An immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage‐dependent mechanism
Mesenchymal stromal/stem cells (MSCs) have emerged as a promising approach against myocardial infarction. Due to hostile hyperinflammation, however, poor retention of transplanted cells seriously impedes their clinical applications. Proinflammatory M1 macrophages, which rely on glycolysis as their m...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189442/ https://www.ncbi.nlm.nih.gov/pubmed/37206202 http://dx.doi.org/10.1002/btm2.10471 |
_version_ | 1785043087768158208 |
---|---|
author | Xiao, Weizhang Chen, Ming Zhou, Wenjing Ding, Liang Yang, Ziying Shao, Lianbo Li, Jingjing Chen, Weiqian Shen, Zhenya |
author_facet | Xiao, Weizhang Chen, Ming Zhou, Wenjing Ding, Liang Yang, Ziying Shao, Lianbo Li, Jingjing Chen, Weiqian Shen, Zhenya |
author_sort | Xiao, Weizhang |
collection | PubMed |
description | Mesenchymal stromal/stem cells (MSCs) have emerged as a promising approach against myocardial infarction. Due to hostile hyperinflammation, however, poor retention of transplanted cells seriously impedes their clinical applications. Proinflammatory M1 macrophages, which rely on glycolysis as their main energy source, aggravate hyperinflammatory response and cardiac injury in ischemic region. Here, we showed that the administration of an inhibitor of glycolysis, 2‐deoxy‐d‐glucose (2‐DG), blocked the hyperinflammatory response within the ischemic myocardium and subsequently extended effective retention of transplanted MSCs. Mechanistically, 2‐DG blocked the proinflammatory polarization of macrophages and suppressed the production of inflammatory cytokines. Selective macrophage depletion abrogated this curative effect. Finally, to avoid potential organ toxicity caused by systemic inhibition of glycolysis, we developed a novel chitosan/gelatin‐based 2‐DG patch that directly adhered to the infarcted region and facilitated MSC‐mediated cardiac healing with undetectable side effects. This study pioneered the application of an immunometabolic patch in MSC‐based therapy and provided insights into the therapeutic mechanism and advantages of this innovative biomaterial. |
format | Online Article Text |
id | pubmed-10189442 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101894422023-05-18 An immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage‐dependent mechanism Xiao, Weizhang Chen, Ming Zhou, Wenjing Ding, Liang Yang, Ziying Shao, Lianbo Li, Jingjing Chen, Weiqian Shen, Zhenya Bioeng Transl Med Research Articles Mesenchymal stromal/stem cells (MSCs) have emerged as a promising approach against myocardial infarction. Due to hostile hyperinflammation, however, poor retention of transplanted cells seriously impedes their clinical applications. Proinflammatory M1 macrophages, which rely on glycolysis as their main energy source, aggravate hyperinflammatory response and cardiac injury in ischemic region. Here, we showed that the administration of an inhibitor of glycolysis, 2‐deoxy‐d‐glucose (2‐DG), blocked the hyperinflammatory response within the ischemic myocardium and subsequently extended effective retention of transplanted MSCs. Mechanistically, 2‐DG blocked the proinflammatory polarization of macrophages and suppressed the production of inflammatory cytokines. Selective macrophage depletion abrogated this curative effect. Finally, to avoid potential organ toxicity caused by systemic inhibition of glycolysis, we developed a novel chitosan/gelatin‐based 2‐DG patch that directly adhered to the infarcted region and facilitated MSC‐mediated cardiac healing with undetectable side effects. This study pioneered the application of an immunometabolic patch in MSC‐based therapy and provided insights into the therapeutic mechanism and advantages of this innovative biomaterial. John Wiley & Sons, Inc. 2022-12-13 /pmc/articles/PMC10189442/ /pubmed/37206202 http://dx.doi.org/10.1002/btm2.10471 Text en © 2022 The Authors. Bioengineering & Translational Medicine published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Xiao, Weizhang Chen, Ming Zhou, Wenjing Ding, Liang Yang, Ziying Shao, Lianbo Li, Jingjing Chen, Weiqian Shen, Zhenya An immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage‐dependent mechanism |
title | An immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage‐dependent mechanism |
title_full | An immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage‐dependent mechanism |
title_fullStr | An immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage‐dependent mechanism |
title_full_unstemmed | An immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage‐dependent mechanism |
title_short | An immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage‐dependent mechanism |
title_sort | immunometabolic patch facilitates mesenchymal stromal/stem cell therapy for myocardial infarction through a macrophage‐dependent mechanism |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189442/ https://www.ncbi.nlm.nih.gov/pubmed/37206202 http://dx.doi.org/10.1002/btm2.10471 |
work_keys_str_mv | AT xiaoweizhang animmunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism AT chenming animmunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism AT zhouwenjing animmunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism AT dingliang animmunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism AT yangziying animmunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism AT shaolianbo animmunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism AT lijingjing animmunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism AT chenweiqian animmunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism AT shenzhenya animmunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism AT xiaoweizhang immunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism AT chenming immunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism AT zhouwenjing immunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism AT dingliang immunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism AT yangziying immunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism AT shaolianbo immunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism AT lijingjing immunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism AT chenweiqian immunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism AT shenzhenya immunometabolicpatchfacilitatesmesenchymalstromalstemcelltherapyformyocardialinfarctionthroughamacrophagedependentmechanism |